Research Article
Comprehensive Analysis Reveals PTK6 as a Prognostic Biomarker Involved in the Immunosuppressive Microenvironment in Breast Cancer
Figure 5
Differential PTK6 expression in various clinicopathological parameters, including (a) age, (b) T stage, (c) M stage, (d) N stage, (e) pathologic stage, (f) histological type, (g) PR status, (h) ER status, and (i) HER2 status. , , and .
(a) |
(b) |
(c) |
(d) |
(e) |
(f) |
(g) |
(h) |
(i) |